ArgoBio

Argobio is a startup studio based in Paris, France, dedicated to transforming cutting-edge innovations into breakthrough biotechnology companies. Argobio sources innovative early-stage therapeutic projects from renowned European academic research institutions, with a focus on rare diseases, neurological disorders, oncology, and immunology. The studio selects and incubates these projects with the goal of creating biotech companies and developing them to significant Series A financing. Argobio, together with a team of experienced biotech entrepreneurs, provides extensive expertise in the discovery and development of new drugs.